Search Results - "Gettinger SN"

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer.

Authors: Huang, Dingzhi Lin, Gen Chu, Qian et al.

Source: Thoracic Cancer. Dec2023, Vol. 14 Issue 34, p3421-3429. 9p.

Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.

Authors: Anobile, Dario Pasquale Barbar, Layla Maucotel, Emile et al.

Source: PLoS Biology. 6/18/2026, Vol. 24 Issue 6, p1-21. 21p.

Extreme procalcitonin elevation without infection in a patient with lung adenocarcinoma undergoing transformation to small-cell lung carcinoma: a case report.

Authors: Jug, Martina Jegorovic, Boris Stevanovic, Goran et al.

Source: Oncologie (De Gruyter). May2026, p1. 8p. 2 Illustrations, 5 Charts.

Non-ablative focused ultrasound induces an adaptive immune response to suppress pancreatic cancer: a preclinical study.

Authors: Park, Eun-Joo Ahn, Yundeok Cheon, Yuri et al.

Source: Ultrasonography. May2026, Vol. 45 Issue 3, p274-285. 12p.

Metastatic malignant melanoma with obstructive jaundice: a case report.

Authors: D'Souza, Adelyn Jariwala, Saloni Hiteshkumar Shetty, Yajnesh C et al.

Source: Gulhane Medical Journal. 2025, Vol. 67 Issue 4, p285-288. 4p.

Successful Treatment of Refractory Immune-Mediated Colitis and Duodenitis with Tofacitinib.

Authors: Misawa, Noboru Higurashi, Takuma Inoue, Kojiro et al.

Source: Case Reports in Gastroenterology. 2025, Vol. 19 Issue 1, p621-629. 9p.

A computational analysis of the oncogenic and anti-tumor immunity role of P4HA3 in human cancers.

Authors: Huang, Hong Yan Zhang, Fu Wei Yu, Jie et al.

Source: PLoS Computational Biology. 11/6/2024, Vol. 20 Issue 11, p1-19. 19p.

Immunotherapy and liver cancer research trends and the 100 most cited articles: A bibliometric analysis.

Authors: Kong, Yang Wang, Yizhi Yang, Qifan et al.

Source: Technology & Health Care. 2024, Vol. 32 Issue 6, p5141-5155. 15p.

A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC).

Authors: McMillan, Matthew T. Reyngold, Marsha Crane, Christopher H. et al.

Source: BMC Cancer. 9/2/2025, Vol. 25 Issue 1, p1-7. 7p.

Adoptive cell therapies in thoracic malignancies: a comprehensive review.

Authors: Garitaonaindia Y Martínez-Cutillas M Uribarren M et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Jul; Vol. 28 (7), pp. 2435-2448. Date of Electronic Publication: 2025 Jan 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Two decades of research on drug resistance in renal cell carcinoma.

Authors: Huang Y Tang Z Xu H et al.

Source: Discover oncology [Discov Oncol] 2026 May 23; Vol. 17 (1). Date of Electronic Publication: 2026 May 23.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

티로신 키나제 억제제 치료 후 상피세포 성장인자 수용체 돌연변이 폐선암의 췌장 전이 병변에서 발생한 소세포암 전환

Alternate Title: Small Cell Transformation in Pancreatic Metastasis from EGFR-Mutated Lung Adenocarcinoma Following TKI.

Authors: Seo, Wootaek Kim, Hyeon-Gi Lim, Hee-Eon et al.

Source: Korean Journal of Pancreas & Biliary Tract / Daehan Chwedamdo Haghoeji. Apr2025, Vol. 30 Issue 2, p76-80. 5p.

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.

Authors: Wang, Wenxian Wang, Qian Xu, Chunwei et al.

Source: Thoracic Cancer. Dec2022, Vol. 13 Issue 23, p3420-3430. 11p.

Clinical characteristics and outcomes of surgically treated melanoma brain metastases: a single-center case series.

Authors: Ivetić, Dražen Stanković, Svetozar Salatić, Igor et al.

Source: Egyptian Journal of Neurosurgery. 1/8/2026, Vol. 41 Issue 1, p1-6. 6p.

Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy.

Authors: Hu, Shuyi Wu, Zipeng Dai, Yingying et al.

Source: Cancer Biology & Medicine. Dec2025, Vol. 22 Issue 12, p1544-1552. 9p.

TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.

Authors: Liu, Jia Wang, Yiming Wei, Xiaoxia et al.

Source: Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p1871-1887. 17p.

Impact of the PD-1/PD-L1 inhibitor SCL-1 on MDA-MB231 tumor growth in a humanized MHC-double knockout NOG mouse model.

Authors: Ikeya, Tomoatsu Ashizawa, Tadashi Kanematsu, Akari et al.

Source: Scientific Reports. 7/24/2025, Vol. 15 Issue 1, p1-11. 11p.

Immuno-Activated, Highly Expressing PD-1 Phenotype in Hepatocellular Carcinoma Is Associated with a Lower Recurrence Rate.

Authors: Hess, Gabriel F. Ercan, Caner Wilhelm, Alexander et al.

Source: Pathobiology. 2025, Vol. 92 Issue 3, p157-168. 12p.

Safety of nivolumab in treating Indian patients with non-small-cell lung carcinoma and renal cell carcinoma: A prospective multicenter study.

Authors: Prabhash, Kumar Patil, Shekar Malik, Prabhat S et al.

Source: Cancer Research, Statistics & Treatment. Jan-Mar2025, Vol. 8 Issue 1, p12-20. 9p.

Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.

Authors: Zhong, Yiye Le, Huangying Zhang, Xue et al.

Source: Journal of Hematology & Oncology. 5/23/2024, Vol. 17 Issue 1, p1-6. 6p.